Article ; Online: DPP-IV Inhibitor-Associated Angioedema in Patient With Known History of ACE Inhibitor Angioedema.
Journal of investigative medicine high impact case reports
2021 Volume 9, Page(s) 23247096211033049
Abstract: The patient is a 69-year-old male with a past medical history of intellectual disability, hypertension, type 2 diabetes mellitus, and angiotensin-converting enzyme (ACE) inhibitor-associated angioedema who presented to the emergency department with ... ...
Abstract | The patient is a 69-year-old male with a past medical history of intellectual disability, hypertension, type 2 diabetes mellitus, and angiotensin-converting enzyme (ACE) inhibitor-associated angioedema who presented to the emergency department with difficulty breathing. On physical examination, the patient had significant facial edema. Nasal fiber-optic visualization revealed extensive airway edema involving the supraglottic region and the arytenoids. The patient was successfully intubated through the collective teamwork of ENT, anesthesia, and critical care teams. He was managed in the intensive care unit until recovery. Workup for markers for allergic causes of angioedema were within normal limits. Further investigation revealed that symptoms developed following the initiation of a dipeptidyl peptidase 4 (DPP-IV) inhibitor. The angiotensin-converting enzyme and DPP-IV play a significant role in the metabolism of bradykinin and substance P to their inactive metabolites. The complex interplay between the enzymes in the high-molecular-weight kininogen (HWMK) system may increase the risk of angioedema in patients with a known history of ACE inhibitor-associated angioedema when placed on a DPP-IV inhibitor. This case report highlights the pathophysiology involved. |
---|---|
MeSH term(s) | Aged ; Angioedema/chemically induced ; Angioedema/diagnosis ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Bradykinin ; Diabetes Mellitus, Type 2 ; Dipeptidyl-Peptidase IV Inhibitors/adverse effects ; Humans ; Male |
Chemical Substances | Angiotensin-Converting Enzyme Inhibitors ; Dipeptidyl-Peptidase IV Inhibitors ; Bradykinin (S8TIM42R2W) |
Language | English |
Publishing date | 2021-07-08 |
Publishing country | United States |
Document type | Case Reports ; Journal Article |
ZDB-ID | 2710326-2 |
ISSN | 2324-7096 ; 2324-7096 |
ISSN (online) | 2324-7096 |
ISSN | 2324-7096 |
DOI | 10.1177/23247096211033049 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.